Document is current
Any future updates will be listed below
-
Authors
Schmidt, Linea https://orcid.org/0009-0006-3014-4058
Ibing, Susanne https://orcid.org/0000-0003-0445-7588
Borchert, Florian
Hugo, Julian
Marshall, Allison A.
Peraza, Jellyana
Cho, Judy H. https://orcid.org/0000-0002-7959-0466
Böttinger, Erwin P.
Renard, Bernhard Y. https://orcid.org/0000-0003-4589-9809
Ungaro, Ryan C.
- License Information
-
More Information
Article History
Received: 26 November 2024
Accepted: 10 December 2025
First Online: 14 January 2026
Competing interests
: R.C.U. has served as a consultant and/or advisory board member for AbbVie, Bristol Myers Squibb, Celltrion, Inotrem, Lilly, Janssen, Pfizer, Roivant, and Takeda. B.Y.R. has served as a consultant and/or holds intellectual property rights commercialized by Seqstant, Biontech, Genentech (Roche). The remaining authors declare no competing interests.
